Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-01-05 @ 8:55 PM
Study NCT ID:
NCT02144194
Status:
UNKNOWN
Last Update Posted:
2017-02-09
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca
Sponsor:
Cancer Research Group - Collaborative Group, Beirut, Lebanon.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2017-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-12
Completion Date Type:
ESTIMATED
First Submit Date:
2014-05-15
First Submit QC Date:
None
Study First Post Date:
2014-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-07
Last Update Post Date:
2017-02-09
Last Update Post Date Type:
ESTIMATED